Valeritas Holdings is a commercial-stage medical technology company focused on improving health for people with diabetes by developing and commercializing technologies. Co.'s product, V-Go® Wearable Insulin Delivery device, is an all-in-one basal-bolus insulin delivery option for patients with type 2 diabetes that is worn like a patch and can eliminate the need for taking multiple daily shots. Co. developed V-Go utilizing its technology, the h-Patch platform, as a patient-focused solution to address the challenges of insulin therapies. Co.'s h-Patch platform facilitates the subcutaneous delivery of injectable medicines to patients across a range of therapeutic areas.

VLRX — News

VLRX — Price Chart